Skip To Main Content
E. E. Vokes on Muck Rack

E. E. Vokes

As seen in: Annals of Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to E. E. Vokes’s profile

Articles by E. E. Vokes

Hypomagnesaemia and its management following treatment with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs): Results from 3 randomized studies of necitumumab (NECI) plus chemotherapy in first-line treatment of patients with stage

|
By E. E. Vokes, M. A. Socinski, D. R. Spigel, L. Paz-Ares
| Annals of Oncology Verified
Background: Hypomagnesaemia is a known side effect of certain chemotherapies and an established class effect of EGFR mAbs. We present analyses of hypomagnesaemia and its management from 3 clinical trials of NECI, a human IgG1 anti-EGFR mAb recently approved in the US and the EU for the treatment of advanced squamous NSCLC. Methods: Three randomized global trials of 1st-line treatment for stage IV NSCLC were included in this analysis.
Open in Who Shared Issue with article?
Show More